SOMNOSYNC

SOMNOSYNC

Otto-Hahn-Str. 3 D-71364 Winnenden

The revolution of screening - REM Phase Detection in a surprisingly small package

How well does the company suit you?

Start matching

Your benefits within the company

Become part of an innovative team
Become an Investor
Become a Co-Founder
Training opportunities
Regular team events
Modern work equipment

Study categories

  • Engineering
  • Media and Communications

Departments

  • Research / Development / Science

Degree

  • Master
  • Diploma

Entry types

  • Part time

German knowledge

  • Business fluent (C1-C2)

English knowledge

  • Business fluent (C1-C2)

Insights

We are developing a novel screening tool for REM sleep analysis that possesses a unique global selling proposition. This will make it possible, for the first time, to adequately analyze REM sleep behavior disorder (RBD)—even in a home environment. RBD is of particular clinical significance as a potential early stage of neurodegenerative diseases, given that a large proportion of patients with RBD go on to develop Parkinson’s disease or related syndromes over a period of 8 to 15 years. Market launch is scheduled for 2030.


SOMNOSYNC

SOMNOSYNC

The revolution of screening - REM Phase Detection in a surprisingly small package

Industries

Medical Technology Science & Research

Employees in Germany:

2